$EVH Income Statement | Understand Stock

$EVH

$4.42 -$0.11 (2.43%) Close

$EVH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations and comprehensive income (loss)

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Transformation Services
Platforms And Operations Services
Total revenue

Expenses
Cost of revenue
Selling, general and administrative expenses
Depreciation and amortization expenses
(Gain) loss on disposal of non-strategic assets
Right-of-use asset impairment
Change in fair value of contingent consideration
Operating expenses

Operating loss
Interest income
Impairment of equity method investments
Interest expense
Gain (loss) from equity method investees
Gain on transfer of membership
Loss on extinguishment/repayment of debt
Loss on option exercise
Extinguishment of Series A Preferred Stock and other refinancing fees
Change in tax receivables agreement liability
Other expense, net
Loss before income taxes
Benefit from income taxes
Net loss attributable to non-controlling interests
Loss from continuing operations
Loss from discontinued operations, net of tax
Income (loss) before preferred dividends and accretion of Series A Preferred Stock
Dividends and accretion of Series A Preferred Stock including excise tax
Net loss attributable to common shareholders of Evolent Health, Inc. - basic
Other comprehensive loss, net of taxes, related to:
Foreign currency translation adjustment
Total comprehensive loss
Total comprehensive loss attributable to non-controlling interests
Foreign currency translation adjustment
Total comprehensive loss attributable to common shareholders of Evolent Health, Inc.
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted
Loss per common share
Continuing operations, basic (in dollars per share)
Discontinued operations basic (in dollars per share)
Non-controlling interests, basic (in dollars per share)
Non-controlling interests, diluted (in dollars per share)
Basic (in dollars per share)
Diluted (in dollars per share)

Weighted-average common shares outstanding
Basic (in shares)
Diluted (in shares)

Comments